NCT06162585Active, not recruiting
Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
Long Term Follow-up for Subjects Who Previously Participated in the NTXMCO-002 RESTORE Study
Source: ClinicalTrials.gov · Last updated 24 Mar 2025
Brief summary (registry, in English)
This study will be conducted following Good Clinical Practice (GCP) and International Conference on Harmonization (ICH) guidelines. Eligible subjects will be consented to return for scheduled study visits for this study following their completion in study NTXMCO-002 (RESTORE). They will not receive a second treatment with MCO-010 (or a repeated sham injection) in this study
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 18 (estimated)
- First submitted
- 30 Nov 2023
- Start date
- 8 Dec 2023
- Primary completion date
- Jul 2027
- Lead sponsor
- Nanoscope Therapeutics Inc.
- Diseases
- Retinitis pigmentosa
- NCT number
- NCT06162585
What you commit to
- Study type: Observational
- Planned participants: 18
- From 8 Dec 2023 to the primary completion date, Jul 2027
- 6 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Not applicable. Subjects will be included in this study and will be consented after completion of all assessments at their final RESTORE study visit
Who the study is looking for
- Previously enrolled in study NTXMCO-002 (RESTORE)
- Able to comprehend and give informed consent.
- Able to comply with testing and all protocol tests.
- Agree to participate for the full 3-year duration of follow-up to the best of their ability and barring any unforeseen circumstances.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (6)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Arecibo | Puerto Rico | Unknown status |
| - Coordinator of this site? Confirm its status | Beverly Hills | United States | Unknown status |
| - Coordinator of this site? Confirm its status | Fargo | United States | Unknown status |
| - Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
| - Coordinator of this site? Confirm its status | McAllen | United States | Unknown status |
| - Coordinator of this site? Confirm its status | Pensacola | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.